Konstantin Konstantinov - Jan 24, 2023 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role
Chief Technology Officer
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Konstantin Konstantinov
Stock symbol
CDAKQ
Transactions as of
Jan 24, 2023
Transactions value $
$0
Form type
4
Date filed
1/26/2023, 03:15 PM
Previous filing
Jan 23, 2023
Next filing
Mar 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Stock Option (Right to Buy) Award $0 +145K $0.00 145K Jan 24, 2023 Common Stock 145K $0.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on January 24, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.